Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation
- 1 May 2018
- journal article
- research article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 151, 450-461
- https://doi.org/10.1016/j.ejmech.2018.04.006
Abstract
No abstract availableKeywords
Funding Information
- NIH (NIAID AI062885, UL1TR001439, P30 DA028821)
- UTMB Technology Commercialization Program
- Sanofi Innovation Awards (548813)
- Crohn's & Colitis Foundation of America
- UT system proteomics network
This publication has 32 references indexed in Scilit:
- I2-Mediated Oxidative C–O Bond Formation for the Synthesis of 1,3,4-Oxadiazoles from Aldehydes and HydrazidesThe Journal of Organic Chemistry, 2013
- Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding SitesJournal of Medicinal Chemistry, 2012
- BET domain co-regulators in obesity, inflammation and cancerNature Reviews Cancer, 2012
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- Discovery and Characterization of Small Molecule Inhibitors of the BET Family BromodomainsJournal of Medicinal Chemistry, 2011
- Suppression of inflammation by a synthetic histone mimicNature, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- Structure-based discovery of antibacterial drugsNature Reviews Microbiology, 2010
- Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral OncoproteinsCancer Research, 2004